A ranar 19 ga Agusta, Beijing Innovita Biological Technology Co., Ltd. ("INNOVITA") ta sami takardar shedar MDSAP, wacce ta hada da Amurka, Japan, Brazil, Kanada, da Ostiraliya, wanda zai taimaka wa INNOVITA ta kara bude kasuwannin duniya.
Cikakken sunan MDSAP shine Shirin Audit Na'urar Na'urar Kiwon Lafiya, wanda shine shirin duba guda ɗaya na na'urorin likitanci.Aiki ne tare da membobin Ƙungiyar Kula da Na'urar Lafiya ta Duniya (IMDRF).Manufar ita ce ƙwararriyar hukumar bincike ta ɓangare na uku na iya gudanar da binciken masana'antun na'urorin likitanci don biyan buƙatun QMS/GMP daban-daban na ƙasashe masu shiga.
Hukumomi biyar ne suka amince da aikin, Hukumar Kula da Abinci da Magunguna ta Amurka, Hukumar Lafiya ta Kanada, Hukumar Kula da Kayayyakin Magunguna ta Australiya, Hukumar Lafiya ta Brazil da Ma’aikatar Lafiya, Ma’aikata da Jin Dadi ta Japan.Yana da kyau a faɗi cewa wannan takaddun shaida na iya maye gurbin wasu na'urorin tantancewa da na yau da kullun a cikin ƙasashen da aka ambata a sama, da samun damar kasuwa, don haka buƙatun takaddun shaida suna da yawa.Misali, Kiwon Lafiyar Kanada ta sanar da cewa daga Janairu 1, 2019, MDSAP za ta maye gurbin CMDAS ɗin dole a matsayin shirin sake duba na'urorin likitancin Kanada.
Samun takardar shedar tsarin ƙasashe biyar na MDSAP ba kawai babban amincewar INNOVITA da samfuranta ne daga Ostiraliya, Brazil, Kanada, Amurka, da Japan ba, amma kuma yana taimakawa INNOVITA don ci gaba da faɗaɗa sikelin rajista na ketare na sabon sa. kambi gwajin reagents.A halin yanzu, an yi rajistar gwajin Covid-19 na INNOVITA a cikin kasashe kusan 30, ciki har da Amurka, Brazil, Faransa, Italiya, Rasha, Spain, Portugal, Netherlands, Hungary, Austria, Sweden, Singapore, Philippines, Malaysia, Thailand. , Argentina, Ecuador, Colombia, Peru, Chile, Mexico, da dai sauransu.
An ba da rahoton cewa INNOVITA tana ci gaba da haɓaka aikace-aikacen yin rajista tare da ƙarin ƙasashe da cibiyoyi, tana faɗaɗa sikelin rajistar gwaje-gwajen Covid-19 a ƙasashen waje, gami da neman takardar shedar EU CE (gwajin kai) da FDA ta Amurka sabon gwajin antigen na Covid-19. kit rajista.
Annobar duniya na ci gaba da yaduwa.An sayar da na'urorin gwajin Covid-19 na INNOVITA zuwa kasashe da yankuna sama da 70, kuma sun gudanar da sahihin bincike, cikin sauri da kuma manyan bincike kan kwayar cutar SARS-CoV-2, suna taka muhimmiyar rawa a yakin duniya na Covid-19. annoba.
Lokacin aikawa: Oktoba 18-2021